Remove 2024 Remove Fraud Remove Governance Remove Prescription Drug Pricing
article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass.

article thumbnail

Health Provider News

Hall Render

in billing fraud Arizona system names new CEO Banner Health CEO Peter Fine to retire after 24 years, handing the reins to health system president Four UArizona bioscience startups selected for Flinn Foundation program Gov. s health, hospital chief says Raising Ky.’s

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

operating margin for 2024, misses 2023 target University of Michigan Health-West forms portal to track DEI among suppliers, vendors S. Record-breaking settlement: Here’s why Bon Secours must pay the US government $36.5 ’ ‘We don’t need it all’: R.I.’s Health system settles orthopedic False Claims allegations for $36.5M

article thumbnail

Guest Post – Second Circuit Rejects Manufacturer’s Plan to Share Cost of Expensive Drug with Medicare Part D Beneficiaries

Drug & Device Law

First, the matter underscores the extreme sensitivity of the OIG to prescription drug pricing issues, as the proposed program effectively would remove potential disincentives to manufacturer price increases. This result, however, does clarify a few areas. Nicholson v. Medcom Carolinas, Inc. , 4th 185 (4th Cir.